Just call me Pinocchio because I lied. Last week I said I would review the Sleep Cycle app for this week’s mobile health review, but over the holiday weekend I came across an app that I am so excited about I just have to tell you about it first. But don’t worry, the Sleep Cycle app is already downloaded on my iPhone and I promise to tell you all about it next week. For Crohn’s disease or ulcerative colitis patients like me, GIMonitor by WellApps is a must-have mobile app. If I didn’t already own a smartphone I would buy...
EnteroMedics (St. Paul, Minnesota), a company that develops devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, said it has completed enrollment and device implantation in its ReCharge pivotal trial for obesity.
St. Jude Medical (St. Paul, Minnesota) is making efforts to quell concerns regarding its Riata and Riata ST silicone defibrillation leads following its recent Class I recall - but some analysts say share gain in 2012 will be hard to come by as physicians will continue to be leery of the devices.
Bidding farewell to 2011 will likely be a welcome occasion for most folks in the med-tech industry as the year presented its fair share of regulatory road blocks and other challenges. Heading into 2012, the med-tech analysts at Canaccord Genuity (Toronto) have identified their top picks for 2012.
It’s that time of year again when millions of us in the U.S. make New Year’s resolutions to improve ourselves in some grand way – often by means of getting in shape and/or leading an overall healthier lifestyle. And this year we’re sticking to it – right? Well, at least until mid-February. Fortunately this year there are dozens of free mobile health apps that can help us with our resolutions - or at least make it more fun trying. There’s literally an app for everything from helping you lose weight to tracking your menstrual cycle, monitoring your heart rate, and...
With all the talk these days of budgetary belt-tightening on Capital Hill, it's a bit of a relief to know that at least one healthcare sector will see a surge in federal spending. Not too surprisingly, that sector is healthcare information technology (HIT0.
In today's economic environment one of the biggest testaments to a company's success is its ability to attract new investors and to continue getting money from existing investors. Cohera Medical's (Pittsburgh) most recent financing round is a fitting example of such a testament.
AirXpanders (Palo Alto, California) reported that the first patient has been treated in the AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction(EXPAND trial. XPAND is a prospective, randomized, controlled, open-label pivotal study of the company's AeroForm breast tissue expansion device in mastectomy patients undergoing breast reconstruction.
